Submitted by Anonymous (not verified) on 13 October 2025 - 16:45
Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Date of authorisation: 23/10/2009, Revision: 34, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Date of authorisation: 23/10/2009, Revision: 34, Status: Authorised